Neuway Pharma GmbH:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Neuway Pharma GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10943
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Neuway Pharma GmbH (Neuway) is a provider of preclinical and clinical development for the treatment of central nervous system diseases. The company provides proprietary CNS drug delivery platform facilitates the transport of active drug substances through the blood-brain barrier. Its technology is based on a protein capsule which allows filling of its lumen with therapeutic active compounds. Neuway utilizes proprietary delivery technology, engineered protein capsules to develop therapeutics for orphan CNS diseases. The company offers EPCs which are deployed in a large variety of therapeutic active substances. It concentrates on orphan brain diseases such as Alzheimer’s disease, Parkinson’s disease and multiple sclerosis. Neuway is headquartered in Bonn, Germany.

Neuway Pharma GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Neuway Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Neuway Pharma GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Neuway Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Neuway Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Neuway Pharma GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Neuway Pharma GmbH, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Neuway Pharma Raises Additional USD3.5 Million in Series A Financing 10
Neuway Pharma Raises USD4 Million in Series A Financing 11
Licensing Agreements 12
Neuway Pharma Enters into Licensing Agreement with University of Zurich 12
Neuway Pharma GmbH – Key Competitors 13
Neuway Pharma GmbH – Key Employees 14
Neuway Pharma GmbH – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Neuway Pharma GmbH, Pharmaceuticals & Healthcare, Key Facts 2
Neuway Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Neuway Pharma GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Neuway Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Neuway Pharma GmbH, Deals By Therapy Area, 2012 to YTD 2018 8
Neuway Pharma GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Neuway Pharma Raises Additional USD3.5 Million in Series A Financing 10
Neuway Pharma Raises USD4 Million in Series A Financing 11
Neuway Pharma Enters into Licensing Agreement with University of Zurich 12
Neuway Pharma GmbH, Key Competitors 13
Neuway Pharma GmbH, Key Employees 14

List of Figures
Neuway Pharma GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Neuway Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Neuway Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Neuway Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Neuway Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Neuway Pharma GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Neuway Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Neuway Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Neuway Pharma GmbH:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Stilo International Plc (STL):企業の財務・戦略的SWOT分析
    Summary Stilo International Plc (Stilo) is a technology company that offers cloud content solutions. The company’s products include developer tools, XML cloud conversion and SME authoring. It offers digital content and publishes information to multiple channels such as print, web, CD-ROM, smartphone …
  • An Binh Commercial Joint Stock Bank:企業の戦略的SWOT分析
    An Binh Commercial Joint Stock Bank - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • MiaSole Hi-Tech Corp:電力:M&Aディール及び事業提携情報
    Summary MiaSole Hi-Tech Corp (MiaSole) is an alternative energy company that manufactures, designs, develops, and markets thin-film photovoltaic solar cells and panels. The company's products include flexible solar cells, custom modules and SolarRide. It offers photovoltaic products for large-scale …
  • Gemphire Therapeutics Inc (GEMP):製薬・医療:M&Aディール及び事業提携情報
    Summary Gemphire Therapeutics Inc (Gemphire), formerly Michigan Life Therapeutics LLC, is a clinical stage biopharmaceutical company that develops and commercializes therapies for patients with cardiometabolic disorders, including dyslipidemia and non-alcoholic steatohepatitis (NASH). Its lead produ …
  • Donaldson Company, Inc.:企業の戦略・SWOT・財務分析
    Donaldson Company, Inc. - Strategy, SWOT and Corporate Finance Report Summary Donaldson Company, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Renata Ltd (RENATA):企業の財務・戦略的SWOT分析
    Summary Renata Ltd (Renata), formerly Pfizer Ltd, is a pharmaceutical and animal health product company. The company manufactures generic pharmaceutical products including hormones, contraceptives, anti cancer drugs, oral preparations, and other drugs. Its pharmaceutical product portfolio comprises …
  • WellSky Corp:企業の戦略的SWOT分析
    WellSky Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Kancera AB (KAN):製薬・医療:M&Aディール及び事業提携情報
    Summary Kancera AB (Kancera) is a developer of drug candidates for the treatment of cancer. The company’s pipeline products include fractalkine inhibitor AZD8797, used to stop tumor growth; small molecule HDAC6 inhibitors, for neutralizing blood cancer; small molecule PFKFB3 inhibitors, for stopping …
  • Salk Institute for Biological Studies:製薬・医療:M&Aディール及び事業提携情報
    Summary Salk Institute for Biological Studies (Salk) is a research institute that offers biological research programs. The institute’s areas of research comprise aging and regenerative medicine, cancer biology, immune system biology, metabolism and diabetes, neuroscience and neurological disorders, …
  • Exandal Corp.:企業の戦略・SWOT・財務情報
    Exandal Corp. - Strategy, SWOT and Corporate Finance Report Summary Exandal Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • La Jolla Pharmaceutical Company (LJPC):製薬・医療:M&Aディール及び事業提携情報
    Summary La Jolla Pharmaceutical Company (La Jolla) is a biopharmaceutical company that discovers, develops and commercializes pharmaceutical products for life threatening diseases. The company’s major product includes Giapreza, an injection for intravenous infusion indicated to increase blood pressu …
  • Soil Machine Dynamics Ltd:企業の戦略的SWOT分析
    Soil Machine Dynamics Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • San Diego Gas & Electric Co:電力:M&Aディール及び事業提携情報
    Summary San Diego Gas & Electric Company (SDGE), a subsidiary of Sempra Energy is an energy service provider that offers electric generation, transmission and distribution services. The company also distributes natural gas. Its residential services include payment and bill assistance, start, stop, m …
  • OriGene Technologies Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary OriGene Technologies Inc (OriGene) is a research tool company that develops cDNA. The company creates commercial collection of full-length human cDNAs in expression vector. It develops, manufactures and markets genome research and diagnostic products. OriGene provides products such as qPCR r …
  • CareDx Inc (CDNA):医療機器:M&Aディール及び事業提携情報
    Summary CareDx Inc (CareDx), formerly XDx Inc, is a commercial stage molecular diagnostics company that develops, markets, and delivers diagnostic surveillance solutions. The company offers commercialized testing solution, the AlloMap heart transplant molecular test, is a noninvasive blood test used …
  • Wolfgang Puck Worldwide Inc:企業の戦略・SWOT・財務分析
    Wolfgang Puck Worldwide Inc - Strategy, SWOT and Corporate Finance Report Summary Wolfgang Puck Worldwide Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Orbit International Corp.:戦略・SWOT・企業財務分析
    Orbit International Corp. - Strategy, SWOT and Corporate Finance Report Summary Orbit International Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Endava Limited:企業の戦略・SWOT・財務分析
    Endava Limited - Strategy, SWOT and Corporate Finance Report Summary Endava Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Puretech Health plc (PRTC):製薬・医療:M&Aディール及び事業提携情報
    Summary Puretech Health plc (Puretech), formerly PureTech Ventures LLC, is a biopharmaceutical company that develops medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company develops a microbiome immune system drug-discovery platform and drug ca …
  • Achelios Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Achelios Therapeutics Inc (Achelios) is a biopharmaceutical development company that provides reformulation of non-steroidal anti-inflammatory (NSAID) drug molecules. The company offers therapeutic entity development for the treatment of pain and inflammation. Its lead product includes Topof …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆